Hospital market power, not technologies or regulation, is behind escalating prices, says benefits expert Joseph Jenkins, M.D.

A new FINRA report warns firms they should be ready for reviews on their use of digital investment advice tools.

Alicia H. Munnell, director of the Center for Retirement Research at Boston College, shares her thoughts about why Congress should pass a law mandating auto-enrollment and auto-escalation in 401(k) plans.

The majority of employers expect the importance of non-traditional benefits to grow over the next three to five years, fueled in part by the changing demands of employees.

Companies that have yet to start preparing for the DOL’s proposed changes are already falling behind, said lawyer Tammy McCutchen during SHRM’s legislative conference in Washington, D.C.

How advisers and employers can fine-tune communications to better educate workers about plans and perks.

Campaign issues ranging from paid leave to gender pay gaps will affect the legal landscape for employers, says SHRM’s Mike Aitken.

Steve Miller, the pharmacy benefit manager’s chief medical officer, addresses the key cost drivers and what the PBM is doing to guard against increases.

Hospital market power, not regulation or new medical technologies is behind escalating prices, says benefits expert Joseph Jenkins, M.D.

Nearly nine in 10 adults spend more than two hours each day using a digital device, all the more reason for employers to promote their vision plans.

The Strategic Insurance Agency Alliance partners with LifeLock to offer ID theft protection to employer-clients.

For employers, complying with the FMLA may feel like balancing on a tightrope. Here’s how advisers can assist their clients in managing the process.

Why investment committees should be having discussions about environmental, social and governance criteria, a subset of socially responsible investing and an area of growing interest among employees.

The investment firm announces plans to acquire Honest Dollar, an Austin, Texas-based benefits vendor that targets small and mid-sized businesses.

Generic drugs are usually significantly cheaper for plan sponsors than brand-name drugs. Here’s a look at 10 drugs coming off patent in 2016. And although the FDA hasn’t yet approved generics for many of the following blockbuster drugs that are coming off patent this year, in most cases there are generics in the pipeline, according to Dickson Data Blog.

Benefit issues ranging from the paid leave to the gender pay gap and overtimes rules could drastically affect the legal landscape for employers, said SHRM’s Mike Aitken in Washington, D.C. this week.

The fact that many female workers will fall into poverty when they reach age 65 or older should be a call to action for employers, advisers and policymakers, says the National Institute on Retirement Security.

While few employers offer group coverage, there’s still a market for LTC as a voluntary or individual offering.

Steve Miller, the pharmacy benefit manager’s chief medical officer, addresses the key cost drivers and what the PBM is doing to guard against increases.

Making sure the employer has an account manager dedicated to the effort is a key to success, says David Roddenberry.